Family Medicine

Largest study of multiple health indicators over time finds widening disparities in health by race, despite increased targeted funding.

In a poster presented at ACG, investigators find a new patch test could help patients who are not responding to PPI therapy.

The approval represents the first ever therapy for chronic weight management for obesity caused by a trio of genetic deficiencies.

Inflammatory bowel disease patients were surveyed about their remission or flare-up status, as well as their expectations for a flare-up over the next 2 months.

Dr. Tobias Moeller-Bertram discusses how alternative therapies could replace opioids in the future for chronic pain.

The newest indication coincides with growing concerns that COVID-19 and flu spread will cause unprecedented burden on the US this winter.

The lipid profile changes were not significant after 6 months, while the changes in the lipid profile are due to other factors and not the drugs.

Telemedicine has been associated with improved access to care and clinical efficiency without sacrificing diagnostic accuracy.

A week-long treatment program prevented HCV transmission in 88% of cases.

In data from several studies presented at AHA 2020, investigators tout bempedoic acid in patients with atherosclerotic cardiovascular disease and/or heterozygous familial hypercholesterolemia.

The agency did not find any efficacy or safety issues regarding the potential treatment for adults with schizophrenia or bipolar I disorder.

Adamis plans to address agency concerns regarding the naloxone injection application.

A discrepancy regarding a pre-licensing inspection of a third-party manufacturing facility led to the Complete Response Letter.

The study presented at AAO provides an update on previously shared 6-month data from earlier this year.

Nightware provides vibrations when it senses the user is having a nightmare.

Supernus indicates no efficacy or safety concerns from their pediatric ADHD medication.

Lisa Swanson, MD, and Brad Glick, DO, FAAD, discuss a wide range of dermatological conditions faced by pediatric patients—from acne to atopic dermatitis, and everything in between.

Investigators evaluate 35-year height and BMI trajectories for 200 countries and 65 million participants.

The Norfolk Diabetes Prevention Study is the largest type 2 diabetes prevention trial since the US Diabetes Prevention Program more than 20 years ago.

A new study finds patients with sickle cell disease are moderately adherent to hydroxyurea.

Investigators conducted an educational intervention aimed at strengthening healthcare providers’ readiness to address issues related to medication adherence.

A review of studies seeks the prevalence, determinants and outcomes of iron deficiency anemia in expecting mothers with sickle cell disease.

Skin pigmentation disorders do not always have a cure or treatment, and they may cause social or emotional burdens for the patient.

In a study presented at ACG, investigators find the rate of confirmed HCV infections remained stable pre- and post-interventions.

Research shows dupilumab remains effective in EoE for up to 2 years.